Anchor Therapeutics is a Medical Research business in Cambridge, MA.
Business Name: | Anchor Therapeutics |
Categorized In: | Medical Research |
Address: | 1 Kendall Square # B6101, Cambridge, MA 02139 |
Phone Number: | (617) 715-1999 |
Contact Person: | Frederick Jones, Chief Executive Officer |
Website Address: | anchortx.com |
NAICS Code: | 5417114 |
SIC Code: | 8733 |
Business Type: | B2B (Business to Business) |
Founding Year: | 2006 |
Employee #: | 1 to 4 |
Location Type: | Single Location |
Annual Revenue ($): | Unknown |
Share This Business: | |
Similar Businesses: |
Flagship Ventures-Celexion - Cambridge, MA 02139 Acceleron Pharma - Cambridge, MA 02139 Helicos Biosciences - Cambridge, MA 02139 Helicos Bio Sciences Corp - Cambridge, MA 02139 Curis Inc - Cambridge, MA 02139 Erdman Laboratory at MIT - Cambridge, MA 02139 Massachusetts Institute Of Technology - Cambridge, MA 02139 Viswanath Kasisomayajula Ph D - Cambridge, MA 02139 Vascular Medicine Research - Cambridge, MA 02139 |
Anchor Therapeutics, a stable growing company under Medical Research, is being run by Frederick Jones, Chief Executive Officer. Since , their sales have been favorable and consistent at Unknown. Company location coordinates are: 42.3631,-71.1033.
It can be reached by dialing (617) 715-1999, and you could get in touch with their sales team in 1 Kendall Square # B6101, Cambridge, Massachusetts MA 02139. Visit their website at: anchortx.com to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8733 and NAIC – 5417114. Call the hotline stated above for faster transaction and queries. Anchor Therapeutics would like to hear from you.